| 000 | 01715 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516040736.0 | ||
| 264 | 0 | _c20110912 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0019983 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLämmer, Alexandra B | |
| 245 | 0 | 0 |
_aThe P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo. _h[electronic resource] |
| 260 |
_bPloS one _c2011 |
||
| 300 |
_ae19983 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aElectroencephalography |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xcomplications |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aPurinergic P2 Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aPyridoxal Phosphate _xanalogs & derivatives |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
| 650 | 0 | 4 | _aRotarod Performance Test |
| 650 | 0 | 4 |
_aStroke _xcomplications |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBeck, Alexander | |
| 700 | 1 | _aGrummich, Benjamin | |
| 700 | 1 | _aFörschler, Annette | |
| 700 | 1 | _aKrügel, Thomas | |
| 700 | 1 | _aKahn, Thomas | |
| 700 | 1 | _aSchneider, Dietmar | |
| 700 | 1 | _aIlles, Peter | |
| 700 | 1 | _aFranke, Heike | |
| 700 | 1 | _aKrügel, Ute | |
| 773 | 0 |
_tPloS one _gvol. 6 _gno. 5 _gp. e19983 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0019983 _zAvailable from publisher's website |
| 999 |
_c20872013 _d20872013 |
||